PRMT9 and leukemia: Dong et al. [20] found that PRMT9 activity was elevated in the blasts and leukemia stem cells from patients with acute myeloid leukemia, and PRMT9 inhibition exerted antitumor effects by activating cyclic GMP‐AMP synthase.